TEM
Tempus AI, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$64.34
−0.59%Year over year
Reported trailing growth
- Revenue
- +50.4%
- EBITDA
- +12.0%
- EBIT
- -20.6%
- EPS
- -20.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +30.6%
- EBITDA
- +229.5%
- EPS
- +86.5%
Three-year CAGR
- Revenue
- +58.3%
- EBITDA
- +80.6%
- EBIT
- +63.4%
- Net income
- +65.3%
- EPS
- +69.3%
- Free cash flow
- -16.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026